TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 83 filers reported holding TANGO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,520,226 | +252.3% | 401,441 | +3.9% | 0.00% | – |
| Q2 2023 | $1,283,167 | -18.5% | 386,496 | -3.0% | 0.00% | – |
| Q1 2023 | $1,574,051 | -46.9% | 398,494 | -2.5% | 0.00% | -100.0% |
| Q4 2022 | $2,963,315 | +96.4% | 408,733 | -1.9% | 0.00% | – |
| Q3 2022 | $1,509,000 | -23.6% | 416,770 | -4.3% | 0.00% | – |
| Q2 2022 | $1,974,000 | +114.3% | 435,574 | +258.3% | 0.00% | – |
| Q1 2022 | $921,000 | -32.4% | 121,555 | -2.4% | 0.00% | – |
| Q4 2021 | $1,363,000 | -6.8% | 124,560 | +10.1% | 0.00% | – |
| Q3 2021 | $1,463,000 | – | 113,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,363,975 | $70,098,000 | 40.96% |
| Boxer Capital, LLC | 6,871,642 | $24,875,000 | 1.40% |
| TCG Crossover Management, LLC | 1,172,250 | $4,244,000 | 1.27% |
| Cormorant Asset Management, LP | 4,116,949 | $14,903,000 | 1.04% |
| Bain Capital Life Sciences Investors, LLC | 1,921,790 | $6,957,000 | 0.83% |
| Samsara BioCapital, LLC | 630,000 | $2,281,000 | 0.53% |
| EcoR1 Capital, LLC | 4,201,414 | $15,209,000 | 0.45% |
| Southpoint Capital Advisors LP | 4,500,000 | $16,290,000 | 0.44% |
| HARVARD MANAGEMENT CO INC | 708,385 | $2,564,000 | 0.32% |
| Avoro Capital Advisors LLC | 1,550,000 | $5,611,000 | 0.10% |